402 related articles for article (PubMed ID: 20412300)
1. Prevention and control of biofilm-based medical-device-related infections.
Francolini I; Donelli G
FEMS Immunol Med Microbiol; 2010 Aug; 59(3):227-38. PubMed ID: 20412300
[TBL] [Abstract][Full Text] [Related]
2. Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner.
Donlan RM
Clin Infect Dis; 2011 Apr; 52(8):1038-45. PubMed ID: 21460321
[TBL] [Abstract][Full Text] [Related]
3. Biofilms on medical devices.
Talsma SS
Home Healthc Nurse; 2007 Oct; 25(9):589-94. PubMed ID: 18049256
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial polymers for anti-biofilm medical devices: state-of-art and perspectives.
Francolini I; Donelli G; Crisante F; Taresco V; Piozzi A
Adv Exp Med Biol; 2015; 831():93-117. PubMed ID: 25384665
[No Abstract] [Full Text] [Related]
5. [Implanted medical device-related infections: pathophysiology and prevention].
Lebeaux D; Ghigo JM; Lucet JC
Rev Prat; 2014 May; 64(5):620-5. PubMed ID: 24923044
[TBL] [Abstract][Full Text] [Related]
6. [Biofilms and their significance in medical microbiology].
Cernohorská L; Votava M
Epidemiol Mikrobiol Imunol; 2002 Nov; 51(4):161-4. PubMed ID: 12532903
[TBL] [Abstract][Full Text] [Related]
7. Microbial biofilm formation: a need to act.
Römling U; Kjelleberg S; Normark S; Nyman L; Uhlin BE; Åkerlund B
J Intern Med; 2014 Aug; 276(2):98-110. PubMed ID: 24796496
[No Abstract] [Full Text] [Related]
8. Modification of the surfaces of medical devices to prevent microbial adhesion and biofilm formation.
Desrousseaux C; Sautou V; Descamps S; Traoré O
J Hosp Infect; 2013 Oct; 85(2):87-93. PubMed ID: 24007718
[TBL] [Abstract][Full Text] [Related]
9. The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections.
Tamilvanan S; Venkateshan N; Ludwig A
J Control Release; 2008 May; 128(1):2-22. PubMed ID: 18342974
[TBL] [Abstract][Full Text] [Related]
10. [Management of biofilm-associated infections: what can we expect from recent research on biofilm lifestyles?].
Lebeaux D; Ghigo JM
Med Sci (Paris); 2012; 28(8-9):727-39. PubMed ID: 22920875
[TBL] [Abstract][Full Text] [Related]
11. Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control.
Percival SL; Suleman L; Vuotto C; Donelli G
J Med Microbiol; 2015 Apr; 64(Pt 4):323-334. PubMed ID: 25670813
[TBL] [Abstract][Full Text] [Related]
12. Using detachment-promoting agents for the prevention of chronic peritoneal dialysis-associated infections.
Branger B; Marion K; Bergeron E; Perret C; Zabadani B; Reboul P; Freney J
Artif Organs; 2008 Dec; 32(12):918-24. PubMed ID: 19133019
[TBL] [Abstract][Full Text] [Related]
13. A prospective clinical trial on prevention of catheter contamination using the hub protection cap for needleless injection device.
Oto J; Imanaka H; Konno M; Nakataki E; Nishimura M
Am J Infect Control; 2011 May; 39(4):309-13. PubMed ID: 20965611
[TBL] [Abstract][Full Text] [Related]
14. Bacterial biofilms within the clinical setting: what healthcare professionals should know.
Lindsay D; von Holy A
J Hosp Infect; 2006 Dec; 64(4):313-25. PubMed ID: 17046102
[TBL] [Abstract][Full Text] [Related]
15. Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial.
Bosma JW; Siegert CE; Peerbooms PG; Weijmer MC
Nephrol Dial Transplant; 2010 Apr; 25(4):1213-7. PubMed ID: 19948873
[TBL] [Abstract][Full Text] [Related]
16. Impact of microbial attachment on intravascular catheter-related infections.
Zhang L; Gowardman J; Rickard CM
Int J Antimicrob Agents; 2011 Jul; 38(1):9-15. PubMed ID: 21435841
[TBL] [Abstract][Full Text] [Related]
17. Recognition and prevention of nosocomial vascular device and related bloodstream infections in the intensive care unit.
Chittick P; Sherertz RJ
Crit Care Med; 2010 Aug; 38(8 Suppl):S363-72. PubMed ID: 20647794
[TBL] [Abstract][Full Text] [Related]
18. Biofilms, medical devices, and antibiofilm technology: key messages from a recent public workshop.
Phillips KS; Patwardhan D; Jayan G
Am J Infect Control; 2015 Jan; 43(1):2-3. PubMed ID: 25448303
[No Abstract] [Full Text] [Related]
19. Comment on: Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis.
Ho KM
J Antimicrob Chemother; 2010 Apr; 65(4):811-4. PubMed ID: 20142265
[No Abstract] [Full Text] [Related]
20. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections.
Raad II; Fang X; Keutgen XM; Jiang Y; Sherertz R; Hachem R
Curr Opin Infect Dis; 2008 Aug; 21(4):385-92. PubMed ID: 18594291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
